{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:58:40Z","timestamp":1789916320709,"version":"4.0.1"},"reference-count":157,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.18632\/oncotarget.7837","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T04:15:11Z","timestamp":1456892111000},"page":"25087-25102","source":"Crossref","is-referenced-by-count":69,"title":["Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections"],"prefix":"10.18632","volume":"7","author":[{"given":"Maria Lina","family":"Tornesello","sequence":"first","affiliation":[{"name":"Molecular Biology and Viral Oncology Unit, Department of Research, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d - IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Buonaguro","sequence":"additional","affiliation":[{"name":"Molecular Biology and Viral Oncology Unit, Department of Research, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d - IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Izzo","sequence":"additional","affiliation":[{"name":"Hepato-Biliary Surgery Department, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d - IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M.","family":"Buonaguro","sequence":"additional","affiliation":[{"name":"Molecular Biology and Viral Oncology Unit, Department of Research, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d - IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2","volume-title":"Cancer Incidence in Five Continents","volume":"160","author":"Storm","year":"2007"},{"key":"3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Bell","year":"2006","journal-title":"J Hepatol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/sj.bjc.6603649","article-title":"Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review","volume":"96","author":"Franceschi","year":"2007","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Diehl","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.ejca.2012.02.009","article-title":"Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis","volume":"48","author":"Wu","year":"2012","journal-title":"Eur J Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cld.2004.12.009","article-title":"Epidemiology of hepatocellular carcinoma","volume":"9","author":"Diaz","year":"2005","journal-title":"Clin Liver Dis"},{"key":"9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"Plummer","year":"2012","journal-title":"Lancet Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","author":"Feitelson","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"DePinho","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2217\/fon.15.87","article-title":"An overview of new biomolecular pathways in pathogen-related cancers","volume":"11","author":"Buonaguro","year":"2015","journal-title":"Future Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ygeno.2013.04.001","article-title":"Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections","volume":"102","author":"Buonaguro","year":"2013","journal-title":"Genomics"},{"key":"14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0031-1276646","article-title":"Genetics of hepatobiliary carcinogenesis","volume":"31","author":"Zucman-Rossi","year":"2011","journal-title":"Semin Liver Dis"},{"key":"15","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","article-title":"Liver cancer: Approaching a personalized care","volume":"62","author":"Mazzaferro","year":"2015","journal-title":"J Hepatol"},{"key":"16","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Chevet","year":"2012","journal-title":"Nat Genet"},{"key":"17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Zucman-Rossi","year":"2007","journal-title":"Hepatology"},{"key":"18","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s12072-011-9261-3","article-title":"HBV life cycle and novel drug targets","volume":"5","author":"Blum","year":"2011","journal-title":"Hepatol Int"},{"key":"19","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ejca.2010.03.034","article-title":"Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections","volume":"46","author":"Bernardi","year":"2010","journal-title":"Eur J Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0065-230X(09)03004-8","article-title":"Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis","volume":"103","author":"Neuveut","year":"2009","journal-title":"Adv Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jhep.2009.10.033","article-title":"Mechanisms of HBV-related hepatocarcinogenesis","volume":"52","author":"Buendia","year":"2010","journal-title":"J Hepatol"},{"key":"22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s00535-011-0415-9","article-title":"Hepatitis B virus X gene and hepatocarcinogenesis","volume":"46","author":"Lee","year":"2011","journal-title":"J Gastroenterol"},{"key":"23","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.3748\/wjg.v20.i30.10238","article-title":"Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma","volume":"20","author":"Qadri","year":"2014","journal-title":"World J Gastroenterol"},{"key":"24","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1074\/jbc.M606774200","article-title":"The hepatitis B virus X protein functionally interacts with CREB-binding protein\/p300 in the regulation of CREB-mediated transcription","volume":"282","author":"Neuveut","year":"2007","journal-title":"J Biol Chem"},{"key":"25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1365-2893.2009.01156.x","article-title":"Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis","volume":"17","author":"Zhu","year":"2010","journal-title":"J Viral Hepat"},{"key":"26","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1038\/sj.onc.1208827","article-title":"Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1","volume":"24","author":"Jang","year":"2005","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1158\/0008-5472.CAN-07-0529","article-title":"Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4\/6-pRb-E2F1 pathway","volume":"67","author":"Jang","year":"2007","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/sj.onc.1209138","article-title":"Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma","volume":"25","author":"Feitelson","year":"2006","journal-title":"Oncogene"},{"key":"29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ijc.28697","article-title":"Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway","volume":"135","author":"Tang","year":"2014","journal-title":"Int J Cancer"},{"key":"30","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.1074\/jbc.M108025200","article-title":"Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines","volume":"277","author":"Andrisani","year":"2002","journal-title":"J Biol Chem"},{"key":"31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2005.06.009","article-title":"Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin","volume":"19","author":"Lai","year":"2005","journal-title":"Mol Cell"},{"key":"32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2010.09.018","article-title":"Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt\/beta-catenin signaling","volume":"300","author":"Jung","year":"2011","journal-title":"Cancer Lett"},{"key":"33","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1002\/hep.25899","article-title":"Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6","article-title":"Hepatitis B virus X protein inhibits nucleotide excision repair","volume":"80","author":"Harris","year":"1999","journal-title":"Int J Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/JVI.02440-14","article-title":"The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival","volume":"89","author":"Bouchard","year":"2015","journal-title":"J Virol"},{"key":"36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/286533a0","article-title":"Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma","volume":"286","author":"Tiollais","year":"1980","journal-title":"Nature"},{"key":"37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/286531a0","article-title":"Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line","volume":"286","author":"Shafritz","year":"1980","journal-title":"Nature"},{"key":"38","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJM198110293051807","article-title":"Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens","volume":"305","author":"Kew","year":"1981","journal-title":"N Engl J Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.3748\/wjg.v20.i20.6236","article-title":"Role of hepatitis B virus DNA integration in human hepatocarcinogenesis","volume":"20","author":"Kawada","year":"2014","journal-title":"World J Gastroenterol"},{"key":"40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Liu","year":"2012","journal-title":"Nat Genet"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12807","article-title":"Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma","author":"Pollicino","year":"2015","journal-title":"Liver Int"},{"key":"42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jubb","year":"2012","journal-title":"Genome Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/gut.2004.054452","article-title":"Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas","volume":"54","author":"Paterlini-Brechot","year":"2005","journal-title":"Gut"},{"key":"44","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1038\/sj.onc.1206492","article-title":"Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene","volume":"22","author":"Brechot","year":"2003","journal-title":"Oncogene"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26402","article-title":"Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/hep.25979","article-title":"C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun\/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma","volume":"57","author":"Ng","year":"2013","journal-title":"Hepatology"},{"key":"47","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/carcin\/bgs406","article-title":"Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations","volume":"34","author":"Lee","year":"2013","journal-title":"Carcinogenesis"},{"key":"48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","article-title":"Viral-human chimeric transcript predisposes risk to liver cancer development and progression","volume":"25","author":"Chan","year":"2014","journal-title":"Cancer Cell"},{"key":"49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2009.02.057","article-title":"The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy","volume":"286","author":"Hainaut","year":"2009","journal-title":"Cancer Lett"},{"key":"50","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1038\/sj.onc.1208732","article-title":"249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma","volume":"24","author":"Montesano","year":"2005","journal-title":"Oncogene"},{"key":"51","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/carcin\/bgq118","article-title":"Effects of the TP53 p R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein","volume":"31","author":"Chemin","year":"2010","journal-title":"Carcinogenesis"},{"key":"52","volume-title":"Hepatitis C Viruses: Genomes and Molecular Biology","author":"Tan","year":"2006"},{"key":"53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Nascimbeni","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"54","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1053\/jhep.2002.36993","article-title":"Fibrosis and disease progression in hepatitis C","volume":"36","author":"Boyer","year":"2002","journal-title":"Hepatology"},{"key":"55","first-page":"3171","article-title":"Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis","volume":"54","author":"Kasai","year":"1994","journal-title":"Cancer Res"},{"key":"56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Knolle","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"57","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4254\/wjh.v4.i12.342","article-title":"Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies","volume":"4","author":"Hassan","year":"2012","journal-title":"World J Hepatol"},{"key":"58","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1053\/j.gastro.2012.01.045","article-title":"Is hepatitis C virus carcinogenic?","volume":"142","author":"McGivern","year":"2012","journal-title":"Gastroenterology"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2011.03.001","article-title":"The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma","volume":"15","author":"Tur-Kaspa","year":"2011","journal-title":"Clin Liver Dis"},{"key":"60","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.3748\/wjg.v20.i23.7104","article-title":"Production and pathogenicity of hepatitis C virus core gene products","volume":"20","author":"Lo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1872-034X.2007.00261.x","article-title":"Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis","volume":"38","author":"Adamek","year":"2008","journal-title":"Hepatol Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/viro.1999.9694","article-title":"Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli","volume":"258","author":"Shimotohno","year":"1999","journal-title":"Virology"},{"key":"63","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/sj.onc.1204372","article-title":"Sustained activation of the Raf\/MEK\/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein","volume":"20","author":"Balsano","year":"2001","journal-title":"Oncogene"},{"key":"64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1006\/viro.2001.1227","article-title":"Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line","volume":"292","author":"Haussinger","year":"2002","journal-title":"Virology"},{"key":"65","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.cellsig.2004.04.005","article-title":"Activation of RB\/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells","volume":"16","author":"bdel-Kader","year":"2004","journal-title":"Cell Signal"},{"key":"66","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1128\/JVI.80.9.4372-4379.2006","article-title":"Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein","volume":"80","author":"Ray","year":"2006","journal-title":"J Virol"},{"key":"67","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/hep.22849","article-title":"Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways","volume":"49","author":"bdel-Kader","year":"2009","journal-title":"Hepatology"},{"key":"68","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.virol.2006.02.023","article-title":"Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes","volume":"349","author":"Ray","year":"2006","journal-title":"Virology"},{"key":"69","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jhep.2013.07.001","article-title":"Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs","volume":"59","author":"Merle","year":"2013","journal-title":"J Hepatol"},{"key":"70","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1099\/0022-1317-82-9-2235","article-title":"p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3","volume":"82","author":"Jang","year":"2001","journal-title":"J Gen Virol"},{"key":"71","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.22857","article-title":"Nonstructural 3\/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase","volume":"49","author":"Bode","year":"2009","journal-title":"Hepatology"},{"key":"72","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1600-0854.2008.00779.x","article-title":"The hepatitis C virus non-structural protein NS5A alters the trafficking profile of the epidermal growth factor receptor","volume":"9","author":"Harris","year":"2008","journal-title":"Traffic"},{"key":"73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02256065","article-title":"The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis","volume":"9","author":"Reyes","year":"2002","journal-title":"J Biomed Sci"},{"key":"74","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1099\/vir.0.015305-0","article-title":"Hepatitis C virus NS5A protein interacts with beta-catenin and stimulates its transcriptional activity in a phosphoinositide-3 kinase-dependent fashion","volume":"91","author":"Harris","year":"2010","journal-title":"J Gen Virol"},{"key":"75","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1038\/onc.2012.484","article-title":"Hepatitis C virus-induced activation of beta-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events","volume":"32","author":"Pawlotsky","year":"2013","journal-title":"Oncogene"},{"key":"76","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.sbi.2013.01.003","article-title":"PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis","volume":"23","author":"Pascal","year":"2013","journal-title":"Curr Opin Struct Biol"},{"key":"77","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/JVI.65.3.1105-1113.1991","article-title":"Structure and organization of the hepatitis C virus genome isolated from human carriers","volume":"65","author":"Okayama","year":"1991","journal-title":"J Virol"},{"key":"78","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023","article-title":"Gene expression patterns in human liver cancers","volume":"13","author":"Brown","year":"2002","journal-title":"Mol Biol Cell"},{"key":"79","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-2006-960171","article-title":"Genomics and signaling pathways in hepatocellular carcinoma","volume":"27","author":"Llovet","year":"2007","journal-title":"Semin Liver Dis"},{"key":"80","first-page":"3939","article-title":"Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method","volume":"62","author":"Hamamoto","year":"2002","journal-title":"Cancer Res"},{"key":"81","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.20375","article-title":"Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling","volume":"40","author":"Thorgeirsson","year":"2004","journal-title":"Hepatology"},{"key":"82","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(03)12775-4","article-title":"Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection","volume":"361","author":"Ishitsuka","year":"2003","journal-title":"Lancet"},{"key":"83","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Glickman","year":"2008","journal-title":"N Engl J Med"},{"key":"84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1479-5876-7-85","article-title":"Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma","volume":"7","author":"Buonaguro","year":"2009","journal-title":"J Transl Med"},{"key":"85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000122603","article-title":"Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma","volume":"51","author":"Du","year":"2008","journal-title":"Intervirology"},{"key":"86","doi-asserted-by":"publisher","first-page":"e56153","DOI":"10.1371\/journal.pone.0056153","article-title":"Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis","volume":"8","author":"Buonaguro","year":"2013","journal-title":"PLoS One"},{"key":"87","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1159\/000151586","article-title":"Molecular pathogenesis and targeted therapy of hepatocellular carcinoma","volume":"31","author":"Kubicka","year":"2008","journal-title":"Onkologie"},{"key":"88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1872-034X.2009.00583.x","article-title":"Molecular targets for liver cancer therapy: From screening of target genes to clinical trials","volume":"40","author":"Aburatani","year":"2010","journal-title":"Hepatol Res"},{"key":"89","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4161\/cbt.9.10.11440","article-title":"MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma","volume":"9","author":"Wang","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"90","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/hep.23008","article-title":"Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression","volume":"50","author":"Sun","year":"2009","journal-title":"Hepatology"},{"key":"91","doi-asserted-by":"publisher","first-page":"e19518","DOI":"10.1371\/journal.pone.0019518","article-title":"Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"92","doi-asserted-by":"publisher","first-page":"e35331","DOI":"10.1371\/journal.pone.003533","article-title":"Role of miR-148a in hepatitis B associated hepatocellular carcinoma","volume":"7","author":"Feitelson","year":"2012","journal-title":"PLoS One"},{"key":"93","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29802","article-title":"Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus","author":"Chiu","year":"2015","journal-title":"Int J Cancer"},{"key":"94","doi-asserted-by":"publisher","first-page":"6980","DOI":"10.1074\/jbc.M109.065987","article-title":"Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator","volume":"285","author":"Kumar","year":"2010","journal-title":"J Biol Chem"},{"key":"95","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1073\/pnas.0707594105","article-title":"MicroRNA-373 induces expression of genes with complementary promoter sequences","volume":"105","author":"Dahiya","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jhep.2009.12.043","article-title":"Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3","volume":"53","author":"Lee","year":"2010","journal-title":"J Hepatol"},{"key":"97","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cellsig.2012.10.013","article-title":"miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A","volume":"25","author":"Wu","year":"2013","journal-title":"Cell Signal"},{"key":"98","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/hep.23660","article-title":"Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1","volume":"52","author":"Sun","year":"2010","journal-title":"Hepatology"},{"key":"99","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1172\/JCI64265","article-title":"Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis","volume":"123","author":"Cheng","year":"2013","journal-title":"J Clin Invest"},{"key":"100","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/bjc.2011.190","article-title":"Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro","volume":"105","author":"Song","year":"2011","journal-title":"Br J Cancer"},{"key":"101","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gendis.2015.01.001","article-title":"MicroRNAs: Role in Hepatitis C Virus pathogenesis","volume":"2","author":"Ray","year":"2015","journal-title":"Genes Dis"},{"key":"102","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.virol.2012.08.039","article-title":"Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance","volume":"433","author":"Wilson","year":"2012","journal-title":"Virology"},{"key":"103","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.virol.2014.06.024","article-title":"MiR-221 accentuates IFNs anti-HCV effect by downregulating SOCS1 and SOCS3","author":"Ren","year":"2014","journal-title":"Virology"},{"key":"104","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.1128\/JVI.00802-13","article-title":"High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1","volume":"87","author":"Yang","year":"2013","journal-title":"J Virol"},{"key":"105","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bjc.6602448","article-title":"Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis","volume":"92","author":"Schirmacher","year":"2005","journal-title":"Br J Cancer"},{"key":"106","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ijc.26063","article-title":"Oncogenetic tree modeling of human hepatocarcinogenesis","volume":"130","author":"Heiss","year":"2012","journal-title":"Int J Cancer"},{"key":"107","doi-asserted-by":"publisher","first-page":"e28404","DOI":"10.1371\/journal.pone.0028404","article-title":"A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma","volume":"6","author":"Xing","year":"2011","journal-title":"PLoS One"},{"key":"108","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/path.2491","article-title":"A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study","volume":"217","author":"Sasaki","year":"2009","journal-title":"J Pathol"},{"key":"109","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/carcin\/bgi178","article-title":"Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma","volume":"26","author":"Buttner","year":"2005","journal-title":"Carcinogenesis"},{"key":"110","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2559.2009.03343.x","article-title":"Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms","volume":"55","author":"Ferrell","year":"2009","journal-title":"Histopathology"},{"key":"111","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/hep.22033","article-title":"Etiology-dependent molecular mechanisms in human hepatocarcinogenesis","volume":"47","author":"Radlwimmer","year":"2008","journal-title":"Hepatology"},{"key":"112","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/hep.22698","article-title":"Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis","volume":"49","author":"Aburatani","year":"2009","journal-title":"Hepatology"},{"key":"113","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-genom-090711-163752","article-title":"Functional genomic studies: insights into the pathogenesis of liver cancer","volume":"13","author":"Han","year":"2012","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"114","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1158\/0008-5472.CAN-08-0742","article-title":"Focal gains of VEGFA and molecular classification of hepatocellular carcinoma","volume":"68","author":"Ramos","year":"2008","journal-title":"Cancer Res"},{"key":"115","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.24372","article-title":"Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition","volume":"54","author":"Wong","year":"2011","journal-title":"Hepatology"},{"key":"116","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1016\/j.febslet.2006.05.032","article-title":"Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma","volume":"580","author":"Han","year":"2006","journal-title":"FEBS Lett"},{"key":"117","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.24495","article-title":"Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"118","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/path.2644","article-title":"Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis","volume":"220","author":"Wong","year":"2010","journal-title":"J Pathol"},{"key":"119","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/hep.22169","article-title":"Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer","volume":"47","author":"Chen","year":"2008","journal-title":"Hepatology"},{"key":"120","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1101\/gad.1672608","article-title":"DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma","volume":"22","author":"Lowe","year":"2008","journal-title":"Genes Dev"},{"key":"121","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1158\/0008-5472.CAN-09-0164","article-title":"Identification of potential driver genes in human liver carcinoma by genomewide screening","volume":"69","author":"Thorgeirsson","year":"2009","journal-title":"Cancer Res"},{"key":"122","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1053\/j.gastro.2011.12.039","article-title":"Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival","volume":"142","author":"Hunter","year":"2012","journal-title":"Gastroenterology"},{"key":"123","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Olivier","year":"2007","journal-title":"Hum Mutat"},{"key":"124","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Levine","year":"2000","journal-title":"Nature"},{"key":"125","first-page":"491","article-title":"Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas","volume":"8","author":"Shih","year":"1993","journal-title":"Oncogene"},{"key":"126","first-page":"2884","article-title":"Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation","volume":"53","author":"Sugimachi","year":"1993","journal-title":"Cancer Res"},{"key":"127","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0014-5793(03)01345-0","article-title":"Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma","volume":"555","author":"Oka","year":"2003","journal-title":"FEBS Lett"},{"key":"128","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1053\/j.gastro.2010.11.034","article-title":"Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma","volume":"140","author":"Thorgeirsson","year":"2011","journal-title":"Gastroenterology"},{"key":"129","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.ejca.2012.03.001","article-title":"Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis","volume":"48","author":"Wu","year":"2012","journal-title":"Eur J Cancer"},{"key":"130","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0002-9440(10)65496-X","article-title":"Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection","volume":"155","author":"Ohgaki","year":"1999","journal-title":"Am J Pathol"},{"key":"131","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/sj.onc.1209824","article-title":"Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas","volume":"26","author":"Perret","year":"2007","journal-title":"Oncogene"},{"key":"132","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"Perret","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"133","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","article-title":"Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas","volume":"21","author":"Liu","year":"2002","journal-title":"Oncogene"},{"key":"134","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ng.903","article-title":"Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma","volume":"43","author":"Zhou","year":"2011","journal-title":"Nat Genet"},{"key":"135","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Shirakihara","year":"2012","journal-title":"Nat Genet"},{"key":"136","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1055\/s-0030-1247134","article-title":"Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma","volume":"30","author":"Zucman-Rossi","year":"2010","journal-title":"Semin Liver Dis"},{"key":"137","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/ng.2391","article-title":"Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma","volume":"44","author":"Cai","year":"2012","journal-title":"Nat Genet"},{"key":"138","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Trans-ancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Hama","year":"2014","journal-title":"Nat Genet"},{"key":"139","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.27198","article-title":"Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification","volume":"60","author":"Choi","year":"2014","journal-title":"Hepatology"},{"key":"140","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Pelletier","year":"2015","journal-title":"Nat Genet"},{"key":"141","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","author":"Zucman-Rossi","year":"2014","journal-title":"Hepatology"},{"key":"142","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Zucman-Rossi","year":"2013","journal-title":"Nat Commun"},{"key":"143","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0014-5793(02)02757-6","article-title":"Variant forms of upstream stimulatory factors (USFs) control the promoter activity of hTERT, the human gene encoding the catalytic subunit of telomerase","volume":"520","author":"Ishikawa","year":"2002","journal-title":"FEBS Lett"},{"key":"144","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Sharpe","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"145","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2217\/fon.15.39","article-title":"Cellular prognostic markers in hepatocellular carcinoma","volume":"11","author":"Buonaguro","year":"2015","journal-title":"Future Oncol"},{"key":"146","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Moreira","year":"2015","journal-title":"Science"},{"key":"147","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Zaheer","year":"2015","journal-title":"N Engl J Med"},{"key":"148","doi-asserted-by":"publisher","first-page":"e27817","DOI":"10.4161\/onci.27817","article-title":"Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy","volume":"3","author":"Soria","year":"2014","journal-title":"Oncoimmunology"},{"key":"149","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jhep.2013.05.031","article-title":"Challenges in cancer vaccine development for hepatocellular carcinoma","volume":"59","author":"Buonaguro","year":"2013","journal-title":"J Hepatol"},{"key":"150","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Lill","year":"2014","journal-title":"Nature"},{"key":"151","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Vesely","year":"2014","journal-title":"Nature"},{"key":"152","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Kannan","year":"2014","journal-title":"N Engl J Med"},{"key":"153","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1200\/JCO.2012.47.7521","article-title":"Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma","volume":"31","author":"Kerkhoven","year":"2013","journal-title":"J Clin Oncol"},{"key":"154","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance","volume":"47","author":"Knolle","year":"2008","journal-title":"Hepatology"},{"key":"155","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jhep.2012.09.008","article-title":"Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells","volume":"58","author":"Herkel","year":"2013","journal-title":"J Hepatol"},{"key":"156","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jhep.2013.02.022","article-title":"A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C","volume":"59","author":"Melero","year":"2013","journal-title":"J Hepatol"},{"key":"157","article-title":"Phase I\/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040","volume":"33","author":"Sangro","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:35:02Z","timestamp":1589211302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":157,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["7837","26943571"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7837","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}